Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2009 Jun 8.
Published in final edited form as: J Am Coll Cardiol. 2005 Aug 16;46(4):735–737. doi: 10.1016/j.jacc.2005.05.025

Heritability of Left Ventricular Mass and Other Morphologic Variables in Caribbean Hispanic Subjects: The Northern Manhattan Family Study

Suh-Hang Hank Juo, Marco R Di Tullio *, Hsiu-Fen Lin, Tanja Rundek, Bernadette Boden-Albala, Shunichi Homma, Ralph L Sacco
PMCID: PMC2692931  NIHMSID: NIHMS99719  PMID: 16098447

To the Editor

Left ventricular (LV) hypertrophy is a risk factor for cardiovascular disease (13) and ischemic stroke (46). Current data suggest that genetic factors and traditional cardiovascular risk factors contribute to left ventricular mass (LVM) and LV hypertrophy. Several studies demonstrated substantial genetic contribution to LVM in white, black, and American Indian populations (712). However, no data exist on heritability of LVM in Hispanic patients.

Echocardiographically derived LVM has been validated by comparison with autopsy data (13). From LVM and relative wall thickness (RWT), three abnormal geometric patterns (i.e., concentric hypertrophy, eccentric hypertrophy, and concentric remodeling) (14) can be derived, and they appear to carry different risks for cardiovascular events (6).

In the current study, we tested for the significance of heritability for several LVM-related phenotypes in the high-risk Caribbean Hispanic families from the ongoing Northern Manhattan Family Study (NOMAFS). The detailed ascertainment scheme has been described elsewhere (15). Transthoracic echocardiography was performed according to the guidelines of the American Society of Echocardiography (16). Left ventricular end-diastolic diameter (LVDD), left ventricular end-systolic diameter (LVSD), interventricular septum (IVS), and posterior wall thickness (PWT) at end diastole were measured. To minimize variability, we took measurements in triplicate and averaged them.

Left ventricular mass was calculated from the corrected American Society of Echocardiography method (13): LVM = 0.8 (1.04 [(LVDD + IVS + PWT)3 − LVDD3]) + 0.6. Heritability of LVM also was assessed after correction for the indices of body size most commonly used in published reports: body surface area (LVM/BSA), height (LVM/HT), and height to the 2.7 power (LVM/HT2.7). The heritability of LVDD, LVSD, IVS, PWT, and RWT also was assessed. Relative wall thickness was calculated according to two formulas: (IVS + PWT)/LVDD and 2 · PWT/LVDD (14). Echocardiographic studies were interpreted by researchers who were blinded to the clinical characteristics. Interob-server variability ranged between 8% and 10%.

All the quantitative phenotypes were expressed as the mean and standard deviation. Log transformations were used for non-normally distributed variables. We used the Sequential Oligogenic Linkage Analysis Routines (SOLAR) package (Southwest Foundation for Biomedical Research, San Antonio, Texas) (17) to estimate heritability. Ascertainment correction was performed for families that were enrolled based on probands’ LVM/BSA ≥75%.

The current study consisted of 623 subjects from 84 families. The mean family size and age were 11 (range, 3 to 53) subjects and 47 (range, 18 to 95) years, respectively. Men comprised 37% of the total. Mean systolic blood pressure (SBP) was 122.1 ± 19.8 mm Hg. Mean body weight was 76 kg, and average height was 162 cm. The prevalence of diabetes, hypertension, and antihypertensive treatment was 14.2%, 40.6%, and 34.5%, respectively. Means and standard deviations of LV parameters are shown in Table 1. The estimates of heritability for the nine LV phenotypes ranged from 0.49 to 0.23 (all p values ≤0.001, except p = 0.002 for LVDD) after adjusting for demographic and cardiovascular risk factors (Table 1). Left ventricular mass had the highest heritability and LVDD the lowest in model 3.

Table 1.

Heritability of LVM and Other Cardiac Morphologic Variables (n = 623)

Heritability
Variance Explained by Covariates
Mean ± SD Model 1 Model 2 Model 3 Model 1 Model 2 Model 3
LVM (g) 179.6 ± 53.8 0.65 0.51 0.49 17% 38% 39%
LVM/BSA (g/m2) 99.5 ± 25.0 0.50 0.49 0.48 10% 13% 14%
LVM/HT (g/m) 110.5 ± 31.0 0.57 0.49 0.48 11% 30% 32%
LVM/HT2.7 48.8 ± 13.8 0.48 0.48 0.47 9% 31% 32%
RWT (IVS + PWT)/LVDD 0.49 ± 0.09 0.27 0.25 0.23 18% 20% 23%
RWT, 2PWT/LVDD 0.48 ± 0.09 0.26 0.26 0.26 16% 18% 20%
LVDD (cm) 4.5 ± 0.46 0.37 0.23 0.23 16% 28% 28%
LVSD (cm) 2.8 ± 0.46 0.41 0.34 0.35 20% 24% 25%
IVS (cm) 1.1 ± 0.21 0.41 0.34 0.33 18% 28% 30%
PWT (cm) 1.1 ± 0.17 0.45 0.36 0.35 16% 27% 29%

Model 1: adjusted for age and gender; model 2: adjusted for age, gender, weight, and height; model 3: adjusted for age, gender, weight, height, systolic blood pressure, diabetes, and antihypertensive medication.

BSA = body surface area; HT = height; IVS = interventricular septum; LVDD = left ventricular end-diastolic diameter; LVM = left ventricular mass; LVSD = left ventricular end-systolic diameter; PWT = posterior wall thickness; RWT = relative wall thickness.

We calculated heritabilities for LVM and LV morphologic parameters while adjusting for different combinations of covariates. The results showed substantial heritabilities for all the phenotypes, with LVM having the strongest heritability. Age, gender, weight, and height accounted for the majority of interindividual variation for LV phenotypes. Additional adjustment for SBP, diabetes, and antihypertensive medication almost yielded the same results. Similar to previous reports (12,18), our data showed weight as the most important single predictor of LVM (explained ~20% of LVM variance). Relative wall thickness showed weaker heritability than LVM, suggesting that LV geometry may be more strongly affected by acquired conditions, such as blood pressure variability and other unknown exposures. The age- and sex-adjusted heritability comprises common genes with pleiotropic effects on risk factors for LV phenotypes, as well as unique genes for LV phenotypes. Further adjustment for other covariates helps remove the genetic factors exerting pleiotropic effects on these known risk factors. The persistently significant heritabilities suggested a substantial genetic influence on LV phenotypes. To our knowledge, no heritability information was available in Hispanic patients, especially those of Caribbean origin. The present study suggests that genetic factors contributing to LVM and its related phenotypes may have similar and, possibly stronger, heritability in Caribbean Hispanic patients as in other race-ethnic subgroups.

The Strong Heart Study (SHS) analyzed heritability in mostly sibling data collected from 13 American Indian tribes in different geographic locations (7). They reported significant but smaller estimates of adjusted heritability than ours (Table 2). Dividing their participants into three SHS centers, Bella et al. (7) found no significant heritability in relative pairs from Arizona. The SHS investigators suspected that the Arizona Indians are a more homogenous population, which may segregate fewer genetic polymorphisms influencing LV parameters. Using white twin pairs recruited from the general population, Swan et al. (8) reported substantial unadjusted heritabilities of LVM and LV geometric data (Table 2). Adjustment for age, gender, blood pressure, and weight reduced the estimate of heritability from 0.69 to 0.53 for LVM (no adjusted heritabilities for other parameters were reported). Mayosi et al. (9) showed lower heritabilities in white families ascertained through hypertensive probands (Table 2). Garner et al. (10) presented adjusted heritability of 0.28 for LVM in white European nuclear families. Using the correlation between relative pairs, Post et al. (12) estimated adjusted heritability of approximately 0.30 for LVM in the Framingham Heart Study. Analyzing data among hypertensive siblings, the HyperGEN study found that African American subjects had higher sibling correlation in LVM compared with white subjects (11) but that white subjects had a higher correlation in RWT than did African American subjects. However, no heritability was presented in their study.

Table 2.

Heritability Estimates in the Recent Studies

Bella et al. (7)* Garner et al. (10) Mayosi et al. (9) Swan et al. (8)§ Post et al. (12)||
Ethnicity American Indian White White White White
Data type Families Nuclear families Families Twins Relative pairs
LVM 0.17 0.28 0.23 0.69 0.24–0.32
RWT 0.17
LVDD 0.33 0.19 0.61
LVSD 0.27
IVS 0.12 0.17 0.34
PWT 0.09 0.06 0.61
*

Adjusting for age, gender, research center, weight, height, systolic blood pressure, heart rate, medications, and diabetes.

Adjusting for weight.

Adjusting for age, gender, systolic blood pressure, weight, waist-hip ratio, and diabetes.

§

No adjustment for all parameters.

||

Adjusting for gender, age, height, weight, and systolic blood pressure: heritability was 0.32 from sibling pairs, 0.30 from parent-child pairs, and 0.24 from second-degree relative pairs.

Abbreviations as in Table 1.

Unlike most previous studies, we assessed the heritability of LVM after correction by the three most commonly used indices of body size. The estimates of heritability of LVM were not significantly affected by the type of indexing chosen, especially for model 3, with the greatest number of covariates (Table 1). This observation suggests that no single body size index appears preferable in studies on adult populations similar to ours. Adjustment for covariates other than body size, age, and gender had almost no influence on estimates of heritability in models 2 and 3.

More than 40% of our subjects were hypertensive, and 34.5% were taking antihypertensive medication. In our models, adjusting for SBP and antihypertensive medication did not appreciably influence the estimates of heritability after accounting for age, gender, weight, and height. Furthermore, excluding all participants taking antihypertensive medications had little effect on heritability estimations, although it yielded less significant p values (data not shown). Therefore, the effect of hypertension and antihypertensive medication may not be substantial in our study.

In summary, our study indicated that significant genetic factors influence the familial resemblance of LVM in the Caribbean Hispanic population. The considerable estimates of heritability provide the basis for our long-term goal of NOMAFS to map and detect genetic variants contributing to LVM and its related phenotypes.

Acknowledgments

Please note: this work was supported by grants from the NINDS R01 NS40807 (to Drs. Juo, Sacco, Boden-Albala, Di Tullio, and Homma) and R01 NS047655 (to Drs. Juo and Sacco). Dr. Di Tullio was supported by a NINDS Mid-Career Investigator Award in Patient-Oriented Research (K24 NS02241). Dr. Lin is supported by the Kaohsiung Medical University fellowship training grant.

The authors thank Robert Sciacca, EngScD, for assistance in data analysis.

References

  • 1.Ghali JK, Liao Y, Cooper RS. Influence of left ventricular geometric patterns on prognosis in patients with or without coronary artery disease. J Am Coll Cardiol. 1998;31:1635–40. doi: 10.1016/s0735-1097(98)00131-4. [DOI] [PubMed] [Google Scholar]
  • 2.Casale PN, Devereux RB, Milner M, et al. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med. 1986;105:173–8. doi: 10.7326/0003-4819-105-2-173. [DOI] [PubMed] [Google Scholar]
  • 3.Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990;322:1561–6. doi: 10.1056/NEJM199005313222203. [DOI] [PubMed] [Google Scholar]
  • 4.Shaper AG, Phillips AN, Pocock SJ, Walker M, Macfarlane PW. Risk factors for stroke in middle aged British men. BMJ. 1991;302:1111–5. doi: 10.1136/bmj.302.6785.1111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Bikkina M, Levy D, Evans JC, et al. Left ventricular mass and risk of stroke in an elderly cohort. The Framingham Heart Study. JAMA. 1994;272:33–6. [PubMed] [Google Scholar]
  • 6.Di Tullio MR, Zwas DR, Sacco RL, Sciacca RR, Homma S. Left ventricular mass and geometry and the risk of ischemic stroke. Stroke. 2003;34:2380–4. doi: 10.1161/01.STR.0000089680.77236.60. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Bella JN, MacCluer JW, Roman MJ, et al. Heritability of left ventricular dimensions and mass in American Indians: the Strong Heart Study. J Hypertens. 2004;22:281–6. doi: 10.1097/00004872-200402000-00011. [DOI] [PubMed] [Google Scholar]
  • 8.Swan L, Birnie DH, Padmanabhan S, Inglis G, Connell JM, Hillis WS. The genetic determination of left ventricular mass in healthy adults. Eur Heart J. 2003;24:577–82. doi: 10.1016/s0195-668x(02)00524-9. [DOI] [PubMed] [Google Scholar]
  • 9.Mayosi BM, Keavney B, Kardos A, et al. Electrocardiographic measures of left ventricular hypertrophy show greater heritability than echocardiographic left ventricular mass. Eur Heart J. 2002;23:1963–71. doi: 10.1053/euhj.2002.3288. [DOI] [PubMed] [Google Scholar]
  • 10.Garner C, Lecomte E, Visvikis S, Abergel E, Lathrop M, Soubrier F. Genetic and environmental influences on left ventricular mass. A family study. Hypertension. 2000;36:740–6. doi: 10.1161/01.hyp.36.5.740. [DOI] [PubMed] [Google Scholar]
  • 11.Arnett DK, Hong Y, Bella JN, et al. Sibling correlation of left ventricular mass and geometry in hypertensive African Americans and whites: the HyperGEN study. Hypertension Genetic Epidemiology Network. Am J Hypertens. 2001;14:1226–30. doi: 10.1016/s0895-7061(01)02200-2. [DOI] [PubMed] [Google Scholar]
  • 12.Post WS, Larson MG, Myers RH, Galderisi M, Levy D. Heritability of left ventricular mass: the Framingham Heart Study. Hypertension. 1997;30:1025–8. doi: 10.1161/01.hyp.30.5.1025. [DOI] [PubMed] [Google Scholar]
  • 13.Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57:450–8. doi: 10.1016/0002-9149(86)90771-x. [DOI] [PubMed] [Google Scholar]
  • 14.Wachtell K, Bella JN, Liebson PR, et al. Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population: the LIFE study. Hypertension. 2000;35:6–12. doi: 10.1161/01.hyp.35.1.6. [DOI] [PubMed] [Google Scholar]
  • 15.Juo SH, Lin HF, Rundek T, et al. Genetic and environmental contributions to carotid intima-media thickness and obesity phenotypes in the Northern Manhattan Family Study. Stroke. 2004;35:2243–7. doi: 10.1161/01.STR.0000142132.20442.d8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978;58:1072–83. doi: 10.1161/01.cir.58.6.1072. [DOI] [PubMed] [Google Scholar]
  • 17.Almasy L, Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet. 1998;62:1198–211. doi: 10.1086/301844. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Verhaaren HA, Schieken RM, Mosteller M, Hewitt JK, Eaves LJ, Nance WE. Bivariate genetic analysis of left ventricular mass and weight in pubertal twins (the Medical College of Virginia twin study) Am J Cardiol. 1991;68:661–8. doi: 10.1016/0002-9149(91)90361-n. [DOI] [PubMed] [Google Scholar]

RESOURCES